Compugen (CGEN) Equity Ratio (2009 - 2025)

Compugen recorded quarterly Equity Ratio of 0.66 in Q4 2025, up 37.4% quarter-over-quarter from 0.48 in Q4 2024, and up 37.4% year-over-year from 0.48 in Q4 2024.

Compugen's Equity Ratio history runs 10 years deep, the most recent figure standing at 0.66 for Q4 2025.

  • In Q4 2025, Equity Ratio rose 37.4% year-over-year to 0.66; the TTM figure through Dec 2025 stood at 0.66 (up 37.4% YoY), while the FY2025 annual figure was 0.66, up 37.4% from the prior year.
  • Equity Ratio came in at 0.66 for Q4 2025 at Compugen, up from 0.48 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.82 in Q4 2022 to a low of 0.48 in Q4 2024.
  • A 5-year average of 0.66 and a median of 0.66 in 2025 frame the typical range for Equity Ratio.
  • Across the five-year window, Equity Ratio plunged 34.49% in 2023 and soared 37.4% in 2025, its largest moves.
  • Compugen's Equity Ratio stood at 0.81 in 2021, then advanced by 2.17% to 0.82 in 2022, then slumped by 34.49% to 0.54 in 2023, then fell by 11.62% to 0.48 in 2024, then soared by 37.4% to 0.66 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods registered 0.66, 0.48, and 0.54 for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 0.04
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 0.42
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.73
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.77
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.21
10 Compugen 234.03 Mn 142.28 Mn 352,000.00 -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.66
Sep 30, 2025 0.45
Jun 30, 2025 0.47
Mar 31, 2025 0.49
Dec 31, 2024 0.48
Sep 30, 2024 0.49
Jun 30, 2024 0.53
Mar 31, 2024 0.52
Dec 31, 2023 0.54
Sep 30, 2023 0.79
Jun 30, 2023 0.80
Mar 31, 2023 0.82
Dec 31, 2022 0.82
Sep 30, 2022 0.80
Jun 30, 2022 0.82
Mar 31, 2022 0.81
Dec 31, 2021 0.81
Sep 30, 2021 0.81
Jun 30, 2021 0.84
Mar 31, 2021 0.85
Dec 31, 2020 0.87
Sep 30, 2020 0.89
Jun 30, 2020 0.89
Mar 31, 2020 0.87
Dec 31, 2019 0.71
Sep 30, 2019 0.73
Jun 30, 2019 0.66
Mar 31, 2019 0.65
Dec 31, 2018 0.70
Sep 30, 2018 0.75
Jun 30, 2018 0.79
Mar 31, 2018 0.78
Dec 31, 2017 0.76
Sep 30, 2017 0.81
Jun 30, 2017 0.85
Mar 31, 2017 0.87
Dec 31, 2016 0.89
Sep 30, 2016 0.90
Jun 30, 2016 0.91
Mar 31, 2016 0.91
Dec 31, 2015 0.91
Sep 30, 2015 0.92
Jun 30, 2015 0.92
Mar 31, 2015 0.93
Dec 31, 2014 0.92
Sep 30, 2014 0.93
Jun 30, 2014 0.81
Mar 31, 2014 0.79
Dec 31, 2013 0.56
Sep 30, 2013 0.49
Jun 30, 2013 0.56
Mar 31, 2013 0.65
Dec 31, 2012 0.61
Sep 30, 2012 0.67
Jun 30, 2012 0.73
Mar 31, 2012 0.65
Dec 31, 2011 0.67
Sep 30, 2011 0.78
Jun 30, 2011 0.80
Mar 31, 2011 0.78
Dec 31, 2010 0.78
Sep 30, 2010 0.91
Jun 30, 2010 0.91
Mar 31, 2010 0.90
Dec 31, 2009 0.91
Sep 30, 2009 0.78
Jun 30, 2009 0.81
Mar 31, 2009 0.76